These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 14722704

  • 1. Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.
    Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E.
    Psychopharmacology (Berl); 2004 May; 173(3-4):398-404. PubMed ID: 14722704
    [Abstract] [Full Text] [Related]

  • 2. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC, Milani RM, Parmar R, Turner JD.
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [Abstract] [Full Text] [Related]

  • 3. Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users.
    Dafters RI, Hoshi R, Talbot AC.
    Psychopharmacology (Berl); 2004 May; 173(3-4):405-10. PubMed ID: 12955295
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 6. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Morgan MJ, Impallomeni LC, Pirona A, Rogers RD.
    Neuropsychopharmacology; 2006 Jul; 31(7):1562-73. PubMed ID: 16292322
    [Abstract] [Full Text] [Related]

  • 10. Memory deficits associated with recreational use of "ecstasy" (MDMA).
    Morgan MJ.
    Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.
    Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott AC.
    J Psychopharmacol; 2003 Dec; 17(4):389-96. PubMed ID: 14870950
    [Abstract] [Full Text] [Related]

  • 13. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
    Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, Fimm B, Sass H.
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):719-25. PubMed ID: 10811694
    [Abstract] [Full Text] [Related]

  • 14. Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis?
    Gouzoulis-Mayfrank E, Becker S, Pelz S, Tuchtenhagen F, Daumann J.
    Biol Psychiatry; 2002 May 01; 51(9):766-9. PubMed ID: 11983191
    [Abstract] [Full Text] [Related]

  • 15. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.
    Parrott AC, Sisk E, Turner JJ.
    Drug Alcohol Depend; 2000 Jul 01; 60(1):105-10. PubMed ID: 10821995
    [Abstract] [Full Text] [Related]

  • 16. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
    Parrott A.
    Hum Psychopharmacol; 2003 Mar 01; 18(2):89-90. PubMed ID: 12590401
    [No Abstract] [Full Text] [Related]

  • 17. The impact of comorbid cannabis and methamphetamine use on mental health among regular ecstasy users.
    Scott LA, Roxburgh A, Bruno R, Matthews A, Burns L.
    Addict Behav; 2012 Sep 01; 37(9):1058-62. PubMed ID: 22607716
    [Abstract] [Full Text] [Related]

  • 18. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J.
    Addict Behav; 2004 Jun 01; 29(4):743-52. PubMed ID: 15135556
    [Abstract] [Full Text] [Related]

  • 19. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM, Parrott AC, Schifano F, Turner JJ.
    Hum Psychopharmacol; 2005 Jun 01; 20(4):249-61. PubMed ID: 15816011
    [Abstract] [Full Text] [Related]

  • 20. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C, Fisk JE.
    J Psychopharmacol; 2007 Sep 01; 21(7):709-17. PubMed ID: 17606476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.